Arrowhead Pharmaceuticals, Inc. (ARWR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
76.14-5.00 (-6.16%)
As of 9:49AM EST. Market open.
Loading interactive chart…
- Business Wire
Arrowhead Pharmaceuticals Files IND for Phase 2b Study of ARO-ANG3 for Treatment of Mixed Dyslipidemia
Arrowhead files IND for ARO-ANG3 to start Phase 2b study in patients with mixed dyslipidemia
- Business Wire
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 First Quarter Results
Arrowhead to release earnings and hold conference call on February 4 2021
- Business Wire
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
© 2021 Verizon Media. All rights reserved.
